openPR Logo
Press release

Cartherics appoints new Chief Scientific Officer

10-17-2023 10:29 AM CET | Health & Medicine

Press release from: Cartherics

/ PR Agency: Teraze Communications

Melbourne, Australia, 17 October 2023 - Cartherics Pty Ltd ("Cartherics" or "Company"), a biotechnology company developing immune cell therapies for the treatment of cancer, announced today that it has appointed Dr Walid Azar as Chief Scientific Officer (CSO), effective immediately. He holds extensive experience from a diverse scientific background encompassing both academic research and the biotechnology industry.

Prior to joining Cartherics three years ago, Dr Azar worked as a molecular biologist at CSL Limited, where he was part of the international R&D team. He brings valuable expertise in cancer research to the CSO role, having completed a PhD in molecular biology and biochemistry at the Murdoch Children's Research Institute and a postdoctoral research fellowship at the Peter MacCallum Cancer Centre, focusing on clear cell carcinoma, a rare subtype of ovarian cancer.

As CSO, Dr Azar will be responsible for overseeing the Company's scientific activities, building on current capabilities, product pipeline, and platforms. This includes ensuring that the Company remains at the forefront of the latest developments in the immune cell therapy space. He will also be focused on managing and leading the team of highly skilled and committed scientists working at Cartherics.

"I am passionate about developing novel treatments for cancer and there is a strong alignment between Cartherics' mission and my commitment to delivering new options for cancer patients. It is great to be working alongside very talented and committed scientists with the same goal," said Dr Azar.
"CAR-T and CAR-NK cell therapies are yet to reach their potential in solid tumours. With the rapid developments in gene editing technologies and our evolving knowledge of the tumour microenvironment and NK cell biology, there is an opportunity for us to significantly improve the efficacy of CAR-NK therapy in solid tumours," Dr Azar added.

Cartherics CEO, Prof Alan Trounson AO, commented: "We are pleased to promote Walid to this important position. He has a strong background in molecular genomics cancer research, and science management, and will be a valuable addition to the Company's executive team. Prof Richard Boyd will remain with the Company as Chief Scientific Advisor, a part-time advisory role, and will act as a mentor for Walid. The combination will enable us to maintain excellence in immunology and genomics/gene editing."

Cartherics Pty Ltd
12 Ferntree Place
Notting Hill VIC 3168
Australia

Cartherics media contact
Christine Filippis
Teraze Communications
Phone: +61 419 119 866
Email: christine@teraze.com.au

About Cartherics
Cartherics is a privately held biotechnology company based in Melbourne, Australia that is rearming the body's immune system to fight cancer.  It is developing cell-based immunotherapies for the treatment of cancer, with a portfolio of CAR-T and CAR-NK cell products.  The Company's allogeneic ("off-the-shelf") cell platform is based upon induced pluripotent stem cells (iPSCs) generated from donated cord blood that can be differentiated into NK cells, T cells and other cells of the immune system.  The iPSCs are genetically engineered to provide enhanced function for the derived NK and other immune cells.

The Company is also developing autologous CAR-T cell therapies. These use the patient's own immune system T cells, which are modified to be effective against the patient's cancer cells. CTH-004 is created by genetically modifying patient T cells to insert a chimeric antigen receptor (CAR) to target a marker (TAG-72) on ovarian cancer cells and delete genes that are involved in suppression of T cell function. https://cartherics.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cartherics appoints new Chief Scientific Officer here

News-ID: 3252108 • Views: …

More Releases from Cartherics

CARTHERICS TO PRESENT AT THE 2025 BIO INTERNATIONAL CONVENTION
CARTHERICS TO PRESENT AT THE 2025 BIO INTERNATIONAL CONVENTION
• Cartherics' Chief Operating Officer, Dr. Ian Nisbet, will be presenting at BIO on Monday 16th June, 2025 at 1.30pm (US EDT). Melbourne, Australia, 28 May 2025 - Cartherics Pty Ltd ("Cartherics" or "Company"), a biotechnology company focused on developing immune cell therapies for cancer and other diseases, announced today that Dr. Ian Nisbet, COO, will present at the upcoming 2025 BIO International Convention June 16-19 2025, in Boston Massachusetts.…
CARTHERICS RAISES OVER $15 MILLION IN OVERSUBSCRIBED PRIVATE FINANCING ROUND TO ADVANCE CELL THERAPY PROGRAMS
CARTHERICS RAISES OVER $15 MILLION IN OVERSUBSCRIBED PRIVATE FINANCING ROUND TO …
• Financing round was significantly oversubscribed by existing investors and new private investors. • Funding will enable the Company to progress clinical trials of its lead CAR-NK cell therapy product, CTH-401, in ovarian cancer and expand its pipeline to additional disease indications. Melbourne, Australia, 1 October 2024 -  Cartherics Pty Ltd ("Cartherics" or "Company"), a biotechnology company developing immune cell therapies for the treatment of cancer and other diseases, is pleased to announce…
CARTHERICS ENTERS AGREEMENTS WITH UNIQUEST, THE UNIVERSITY OF QUEENSLAND AND THE UNIVERSITY OF SYDNEY FOR ADVANCING INNOVATIVE CARDIAC CELLULAR THERAPY
CARTHERICS ENTERS AGREEMENTS WITH UNIQUEST, THE UNIVERSITY OF QUEENSLAND AND THE …
• Cartherics, UniQuest and The University of Sydney enter Technology Licence Agreement for Cartherics' iPSC cell line. • Cartherics, The University of Queensland and The University of Sydney enter Material Transfer Agreement to support development of iPSC-derived cardiomyocytes for the treatment of cardiovascular disease. Melbourne, Australia, 25 July 2024 - Cartherics Pty Ltd ("Cartherics" or "Company"), a biotechnology company developing immune cell therapies for the treatment of cancer, is pleased to announce that…
CARTHERICS GRANTED EUROPEAN PATENT FOR MULTIPLE DEVELOPMENT CANDIDATES
CARTHERICS GRANTED EUROPEAN PATENT FOR MULTIPLE DEVELOPMENT CANDIDATES
Melbourne, Australia, 23 May 2024 - Cartherics Pty Ltd ("Cartherics" or "Company"), a biotechnology company developing immune cell therapies for the treatment of cancer, is pleased to announce that it has been granted its second European Patent from the family represented by the international patent filing WO2017088012. The European Patent No. 3708587 B1, titled 'Genetically Modified Cells and Uses Thereof,' secures a proprietary position for multiple development candidates in…

All 5 Releases


More Releases for CAR

Car Washing Services Market Is Booming So Rapidly with Mister Car Wash, Zips Car …
The Car Washing Services Market has been fragmented based on the productivity of several companies; therefore, each segment and its sub-segments are analyzed in the research report. Furthermore, the report offers 360 views on historical and upcoming growth based on volume, value, production, and consumption. Moreover, it classifies depend on sub-segments, key segments as per the significant regions and offers an in-depth analysis on the competitive edge of the market.…
Car Wash Service Market Boosting the Growth Worldwide: Auto Bell Car Wash, Miste …
The latest study released on the Global Car Wash Service Market by AMA Research evaluates market size, trend, and forecast to 2027. The Car Wash Service market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key…
Car Rental Services Market Forecast to 2028 Covid-19 Impact and Global Analysis …
Car rental services are a process of hiring/renting a car for a limited period from a rental company. Various companies like Uber Technologies, Europcar rent the vehicles for a short period ranging from few hours to weeks. The different types of cars rented by the company include Luxury Car, executive car, and economical car among others. Additionally, vehicle renting agencies also offer other products such as insurance, entertainment systems, and…
Car Rentals Market Growth Strategies and Innovative Technology Transformation by …
Worldwide Market Reports has announced the addition of the "Car Rentals Market Report 2020-2027 Production, Sales And Consumption Status And Prospects Professional Research", The report classifies the global Car Rentals Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. The emergence of own-brand digital ordering platform has been trending in the global Car Rentals market. Car Rentals such as…
Luxury Car Leasing Market Competitors Analysis By German Rent A Car, ANI Technol …
 'Global Luxury Car Leasing Market Research Report' the report is complete with an elaborate research undertaken by prominent analysts and a detailed analysis of the global industry place. The Luxury Car Leasing report is fragmented in several features which include manufacturers, region, type, application, market status, market share, growth rate, future trends, market drivers, opportunities, challenges, emerging trends, risks, entry barriers, sales channels, and distributors which are again elaborated in…
Car Wash Market is Thriving Worldwide 2026 | Super Star Car Wash, Autobell Car W …
This Car Wash Market research report offers you an array of insights about Automotive industry and business solutions that will support to stay ahead of the competition. Systematic investment analysis is also underlined in this Car Wash Market report which forecasts impending opportunities for the market players.This market report is the outcome of persistent efforts lead by knowledgeable forecasters, innovative analysts and brilliant researchers who carries out detailed and diligent…